期刊文献+

VX2肿瘤MSCT灌注与缺氧状态关系的研究

The Relationship Among MSCT Perfusion And Hypoxia in The VX2 Tumor Model
原文传递
导出
摘要 目的研究VX2肿瘤MSCT血流灌注与缺氧状态之间的关系。材料与方法8只腿部肌肉种植VX2肿瘤的新西兰大白兔,分别于肿瘤生长第7、14、21、28天行MSCT灌注扫描,分别测量肿瘤及正常肌肉组织内血流量(BF)、最大强化指数(PEI)、峰值到达时间(TTP)及血容量(BV)作为灌注指标。肿瘤组织行HIF-1α免疫组织化学染色,根据肿瘤细胞着色深度和阳性细胞百分比统计HIF-1α表达等级。不同时间段HIF-1α等级分布分别进行χ2检验,HIF-1α表达等级之间行χ2检验,HIF-1α与CT灌注值行Spearman等级相关分析。结果肿瘤第7、14、21、28天HIF-1α等级由低到高再降低,但其变化差异无统计学意义(χ2=1.49,P=0.22),不同时间段CT灌注BF值与HIF-1α表达存在相关性(r=0.87,P<0.05),其他CT灌注值与HIF-1α表达无明显相关性。结论VX2肿瘤生长过程中均存在缺氧,缺氧状态与CT灌注BF值相关,表明VX2肿瘤血流灌注与肿瘤缺氧状态之间存在依存关系。 Objective To study the relationship of tumor hypoxia and MSCT perfusion parameters of VX2 soft-tissue tumor in the rabbit model during the process of tumor growth. Materials and Methods 8 rabbits were implanted with VX2 tumor tissue in proximal thighs. MSCT perfusion scan were performed on those rabbits with Mx8000 Quad CT in the 7, 14,21,28 days after implant respectively. The 45s-perfusion CT examination was underwent and perfusion maps were produced automatically. Blood flow(BF) , peak enhancement index ( PEI ) , time to peak (TTP) and blood volume ( BV ) were measured by the manually defined ROI within tumor. 2 rabbits were sacrificed every 7 days after CT perfusion, and the resected specimens were stained immunohistochemieally to identified HIF-α for assessment of their stage. Results The HIF-1α staging of 7th, 14th,21st,28th day increase gradually with time and then following decrease. The HIF-1α staging of vary time have no significance difference ( X^2 = 1.49, P = 0.22 ). Significant correlation were observed between BF with HIF- 1α(r =0. 87,P 〈0.05) ,There were no significant associations between PEI,TTP,BV and HIF-1α. Conclusion HIF-1α is an important factor in the regulation of angiogenesis and tumor growth in VX2 soft-tissue tumor. Blood perfusion values correlate positively with HIF-1α and they may reflect the regulation of hypoxia and perfusion partially in tumor.
出处 《临床放射学杂志》 CSCD 北大核心 2009年第7期1018-1021,共4页 Journal of Clinical Radiology
基金 湖北省卫生厅科研基金(JX1B148)资助项目 武汉市青年科技"晨光计划"项目(20055003059-14)
关键词 肿瘤 灌注 缺氧 体层摄影术 X线计算机 动物 Tumor Perfusion Hypoxia Tomography, X-ray computed Animal
  • 相关文献

参考文献14

  • 1Bimer P,Schindl M,Obernmair A,et al.Overexpression of hypoxiainducible factor 1 is a marker for an unfavorable prognosis in earlystage invasive cervical cancer.Cancer Bes,2000,60:4693
  • 2郭芮伶,吴国明,戢福云.缺氧对人小细胞肺癌H446细胞DNA错配修复基因MLH1、MSH2表达的影响及其机制探讨[J].中国癌症杂志,2008,18(1):26-29. 被引量:4
  • 3Rapisarda A,Melillo G.HIF-1 Inhibitors:Novel Opportunities for Cancer Therapy.Aseo Educational Book,2008,2008:543
  • 4Yeo EJ,Chun YS,Cho YS,et al.YC1:a potential anticancer drug targeting hypoxia-inducible factor 1.J Natl Cancer Inst,2003,95:516
  • 5Tsuzuki Y,Fukumura D,Oosthuyse B,et al.Vascular endothelial growth factor(VEGF) modulation by targeting hypoxia-inducible factor-1 alpha-》hypoxia response element-》VEGF cascade differentially regulates vascular response and growth rate in tumors.Cancer Res,2000,60:6248
  • 6Zhong H,Demarzo AM,Langhner E,et al.Overexpression of hypoxi-a-inducible factorl alpha in common human cancers and their metastases.Cancer Res,1999,59:5830
  • 7Ke QD,Costa M.Hypoxia-lnducible Factor-1 (HIF-1).Mol Pharmacol,2006,70:1469
  • 8Melino G.Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy.Mol Cancer Res,2006,4:601
  • 9Jankovic B,Aquino-Parsons C,Raleigh JA,et al.Comparison between pimonidazole binding,oxygen electrode measurements and expression of endogenous hypoxia markers in cancer of the uterine cervix.Cytometry B Clin Cytom,2006,70:45
  • 10Lehtio K,Eskola O,Viljanen T,et al.Imaging porfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.Int J Radiation Oncology Biol Phys,2004,59:971

二级参考文献16

  • 1王建华.肝癌综合介入治疗的现状[J].中华肝脏病杂志,2005,13(10):721-723. 被引量:80
  • 2周承凯,梁惠民,李欣,柳曦.实验兔VX2肝肿瘤模型制作及动脉插管技术探讨[J].介入放射学杂志,2006,15(2):101-104. 被引量:33
  • 3Birner P,Schindl M,Obermair A,et al.Overexpression of hypoxia-inducible factor 1 is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J].Cancer Res,2000,60:4693 -4696.
  • 4Park YN,Kim YB,Yang KM,et al.Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis[J].Arch Pathol Lab Med,2000,124:1061-1065.
  • 5Weidner N,Semple JP,Welch WR,et al.Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J].N Eng J Med,1991,324:1-8.
  • 6Suzuki H,Mori M,Kawaguchi C,et al.Serum vascular endothelial growth factor in the course of hepatocellular carcinoma[J].Int J Oncol,1999,14:1087-1090.
  • 7Zhong H,De Marzo AM,Laughner E,et al.Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases[J].Cancer Res,1999,59:5830-5835.
  • 8Carmeliet P,Dor Y,Herbert JM,et al.Role of HIF-lalpha in hypoxia-mediated apoptosis,cell proliferation and tumour angiogenesis[J].Nature,1998,394:485-490.
  • 9Tsuzuki Y,Fukumura D,Oosthuyse B,et al.Vascular endothelial growth factor (VEGF) modulation by targeting hypoxiainducible factor-lalpha-→ hypoxia response element-→ VEGF cascade differentially regulates vascular response and growth rate in tumors[J].Cancer Res,2000,60:6248-6252.
  • 10Hiroaki M, Nada HK, Liya G,et al. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer[J]. Cancer Lett, 2005, 223( 1 ) : 143-150.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部